首页> Human Reproduction> Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study.

Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study.

导出原文传递

翻译打印收藏纠错

第一作者： Alvarez C

作者： Alvarez C ^[1] ; Alonso-Muriel I ; Garcia G ; Crespo J ; Bellver J ; Simon C ; Pellicer A

作者单位： Instituto Valenciano de Infertilidad (IVI), University of Valencia, Plaza de la Policia Local, 3, 46015 Valencia, Spain. ^[1]

关键词 Adult Dopamine Agonists Embryo Implantation Ergolines Female Humans 成年人多巴胺激动剂麦角林类卵巢过度刺激综合征试点项目妊娠妊娠率

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Human Reproduction

2007年22卷12期

3210-3214页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览2

Human Reproduction

2007年22卷12期

3210-3214页

检索历史清除

Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study.

Human Reproduction

相似文献

同项目论文

Human Reproduction

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study.

Human Reproduction

相似文献

同项目论文

Human Reproduction

相关期刊

检索历史清除